Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
Sarcoma & Soft Tissue / Bone Cancers
-
-
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
-
Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
-
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery
-
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma
-
Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
-
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone
-
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
-
Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma
Categories
Alliance Committee
Browse by Year